Long-term evaluation of the novel radioenhancer NBTXR3 plus radiotherapy in patients with locally advanced soft tissue sarcoma treated in the phase II/III Act.In.Sarc trial.

Sylvie Bonvalot,Piotr Rutkowski,Juliette Thariat,Sébastien Carrère,Anne Ducassou,Sunyach Marie,Péter Ágoston,Angela Hong,A. Mervoyer,Marco Rastrelli,Cecile Le Pechoux,Victor Moreno,Rubi Khaw Li,B. Tiangco,Zsuzsanna Papai,Act.In.Sarc. investigators

Long-term evaluation of the novel radioenhancer NBTXR3 plus radiotherapy in patients with locally advanced soft tissue sarcoma treated in the phase II/III Act.In.Sarc trial.

2021

Sylvie Bonvalot
Piotr Rutkowski
Juliette Thariat
Sébastien Carrère
Anne Ducassou
Sunyach Marie
Péter Ágoston
Angela Hong
A. Mervoyer
Marco Rastrelli
Cecile Le Pechoux
Victor Moreno
Rubi Khaw Li
B. Tiangco
Zsuzsanna Papai
Act.In.Sarc. investigators

11544Background: NBTXR3, a novel radioenhancer activated by radiotherapy (RT) demonstrated superior efficacy, as preoperative treatment, in patients with locally advanced soft tissue sarcoma (LA ST...

Keywords:

Medicine
Soft tissue sarcoma
locally advanced
in patient
Radiology
preoperative treatment
Radiation therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations